🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anna Jaunarajs

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination”.

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination

Vaccine(2025)10.1016/j.vaccine.2025.127959

N/A

0.208DataRank · unranked

3 citations

Lindsey R. Baden, Hana M. El Sahly, Richard T. Davey, Paulina A. Rebolledo, David Diemert +17 more

Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598

Medical Mycology(2024)10.1093/mmy/myae032

N/A

0DataRank · unranked

11 citations

Robert W. Spitz, Erin Hammett, Anna Jaunarajs, Varduhi Ghazaryan, Edward P. Garvey +2 more

Differences in Mpox and Vaccinia Immunity Induced by Non-Replicating and Replicating Vaccinia-Based Vaccines

Vaccines(2025)10.3390/vaccines13050520

N/A

0DataRank · unranked

1 citations

Krystal A. Meza, Yinyi Yu, Chase G. Colbert, Anna Jaunarajs, Azra Blazevic +3 more